TRANSPLANT Act of 2021
USA117th CongressHR-941| House
| Updated: 5/26/2021
Doris O. Matsui
Democratic Representative
California
Cosponsors (23)
Don Young (Republican)David J. Trone (Democratic)Mondaire Jones (Democratic)Ilhan Omar (Democratic)Pete Aguilar (Democratic)Bobby L. Rush (Democratic)Eric Swalwell (Democratic)Tom McClintock (Republican)Madeleine Dean (Democratic)Angie Craig (Democratic)Gus M. Bilirakis (Republican)Kurt Schrader (Democratic)G. K. Butterfield (Democratic)Richard Hudson (Republican)Jahana Hayes (Democratic)Mary Gay Scanlon (Democratic)Julia Brownley (Democratic)Tom Emmer (Republican)Brian K. Fitzpatrick (Republican)Charlie Crist (Democratic)Chellie Pingree (Democratic)Grace F. Napolitano (Democratic)Judy Chu (Democratic)
Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021 This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments. In addition, the Government Accountability Office must report on the regenerative medicine workforce.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Mr. Pallone moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H1752-1754)
DEBATE - The House proceeded with forty minutes of debate on H.R. 941.
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Considered as unfinished business. (consideration: CR H1829)
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109). (text: 04/14/2021 CR H1752-1753)
View VoteMotion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Passed Senate without amendment by Voice Vote.
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S2550)
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S2550)
Message on Senate action sent to the House.
Presented to President.
Signed by President.
Became Public Law No: 117-15.
Health
Advisory bodiesBlood and blood diseasesCell biology and embryologyCongressional oversightGovernment studies and investigationsHealth programs administration and fundingMedical researchOrgan and tissue donation and transplantationResearch administration and funding
TRANSPLANT Act of 2021
USA117th CongressHR-941| House
| Updated: 5/26/2021
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021 This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments. In addition, the Government Accountability Office must report on the regenerative medicine workforce.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Mr. Pallone moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H1752-1754)
DEBATE - The House proceeded with forty minutes of debate on H.R. 941.
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Considered as unfinished business. (consideration: CR H1829)
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 415 - 2 (Roll no. 109). (text: 04/14/2021 CR H1752-1753)
View VoteMotion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Passed Senate without amendment by Voice Vote.
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S2550)
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S2550)
Message on Senate action sent to the House.
Presented to President.
Signed by President.
Became Public Law No: 117-15.
Doris O. Matsui
Democratic Representative
California
Cosponsors (23)
Don Young (Republican)David J. Trone (Democratic)Mondaire Jones (Democratic)Ilhan Omar (Democratic)Pete Aguilar (Democratic)Bobby L. Rush (Democratic)Eric Swalwell (Democratic)Tom McClintock (Republican)Madeleine Dean (Democratic)Angie Craig (Democratic)Gus M. Bilirakis (Republican)Kurt Schrader (Democratic)G. K. Butterfield (Democratic)Richard Hudson (Republican)Jahana Hayes (Democratic)Mary Gay Scanlon (Democratic)Julia Brownley (Democratic)Tom Emmer (Republican)Brian K. Fitzpatrick (Republican)Charlie Crist (Democratic)Chellie Pingree (Democratic)Grace F. Napolitano (Democratic)Judy Chu (Democratic)
Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Advisory bodiesBlood and blood diseasesCell biology and embryologyCongressional oversightGovernment studies and investigationsHealth programs administration and fundingMedical researchOrgan and tissue donation and transplantationResearch administration and funding